FDCDDQ
MDGL icon

Federation des caisses Desjardins du Quebec’s Madrigal Pharmaceuticals MDGL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$509K Sell
973
-273
-22% -$130K ﹤0.01% 1253
2025
Q4 		$726K Buy
1,246
+162
+15% +$82.7K ﹤0.01% 1129
2025
Q3 		$497K Buy
+1,084
New +$404K ﹤0.01% 1239
2020
Q1 		– Sell
-150
Closed -$13.7K – 2307
2019
Q4 		$13.7K Buy
+150
New +$14.5K ﹤0.01% 1824
2019
Q2 		– Sell
-31
Closed -$3.88K – 2305
2019
Q1 		$3.88K Hold
31
– – ﹤0.01% 1853
2018
Q4 		$3.49K Hold
31
– – ﹤0.01% 1835
2018
Q3 		$6.64K Hold
31
– – ﹤0.01% 1824
2018
Q2 		$8.67K Hold
31
– – ﹤0.01% 1783
2018
Q1 		$3.62K Hold
31
– – ﹤0.01% 1929
2017
Q4 		$2.85K Hold
31
– – ﹤0.01% 1956
2017
Q3 		$1.39K Hold
31
– – ﹤0.01% 1972
2017
Q2 		$504 Buy
+31
New +$485 ﹤0.01% 2090

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MDGL Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Madrigal Pharmaceuticals (MDGL) stake by 22% in Q1 2026, selling an estimated $130K and leaving 973 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Federation des caisses Desjardins du Quebec first reported a position in MDGL in Q2 2017 and has held it in 12 quarters since. The position peaked at $726K in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 973 shares of Madrigal Pharmaceuticals worth $509K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec sold 273 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $130K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1253 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Madrigal Pharmaceuticals in Q2 2017 and has held it in 12 quarters since.
  • Federation des caisses Desjardins du Quebec's Madrigal Pharmaceuticals position peaked at $726K in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.